MRI lesion volume measurement in multiple sclerosis and its correlation with disability: a comparison of fast fluid attenuated inversion recovery (fFLAIR) and spin echo sequences

OBJECTIVES To assess whether multiple sclerosis lesion volume measurements derived using the fast fluid attenuated inversion recovery (fFLAIR) sequence show better reproducibility or correlation with disability than those derived using the conventional spin echo (CSE) sequence. METHODS Part I: twenty five patients with multiple sclerosis were scanned with CSE, fast spin echo (FSE), and fFLAIR. Lesion volume was determined twice for each sequence using a local threshold segmentation technique. Part II: fifty six patients with multiple sclerosis were scanned with CSE and fFLAIR. Total and regional brain lesion volumes were compared with the Kurtzke extended disability scale (EDSS) and functional systems scores (FSS). RESULTS Part I: analysis times were significantly longer for CSE than for FSE or fFLAIR. There was no significant difference in the reproducibility of the three sequences. Part II: total lesion volumes were similar but posterior fossa lesion volumes were significantly greater for CSE and subcortical lesion volumes significantly greater for fFLAIR. There was a significant correlation between total volume and EDSS with both sequences (CSEr=0.49; fFLAIR r=0.44). Correlations for the two sequences showed minor differences when anatomical region and FSS were considered separately. CONCLUSIONS CSE, FSE, and fFLAIR are equally reproducible; FSE yields lower volumes than CSE; fFLAIR gives similar volumes to CSE but underscores the posterior fossa. Overall clinical correlations are similar for CSE and fFLAIR.

[1]  A. Thompson,et al.  Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[2]  F. Barkhof,et al.  Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis , 1996, Annals of neurology.

[3]  W. I. McDonald,et al.  Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis , 1994, Neurology.

[4]  F Barkhof,et al.  Disappearance of multiple sclerosis lesions with severely prolonged T1 on images obtained by a FLAIR pulse sequence. , 1996, Magnetic resonance imaging.

[5]  D G Altman,et al.  Statistics Notes: Measurement error proportional to the mean , 1996, BMJ.

[6]  C. Jack,et al.  Contrast optimization of fluid‐attenuated inversion recovery (flair) imaging , 1995, Magnetic resonance in medicine.

[7]  C. Granger,et al.  Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis , 1996, Annals of neurology.

[8]  G. Barker,et al.  Correction of intensity nonuniformity in MR images of any orientation. , 1993, Magnetic resonance imaging.

[9]  D. Miller,et al.  Lesion volume measurement in multiple sclerosis: How important is accurate repositioning? , 1996, Journal of magnetic resonance imaging : JMRI.

[10]  I. Moseley,et al.  Fast FLAIR of the brain: the range of appearances in normal subjects and its application to quantification of white-matter disease , 1997, Neuroradiology.

[11]  H. Tobi,et al.  Correlating MRI and clinical disease activity in multiple sclerosis , 1995, Neurology.

[12]  J C Gore,et al.  The Loss of Small Objects in Variable TE Imaging: Implications for FSE, RARE, and EPI , 1992, Magnetic resonance in medicine.

[13]  J C Gore,et al.  Factors influencing contrast in fast spin-echo MR imaging. , 1992, Magnetic resonance imaging.

[14]  G. Barker,et al.  Detection of multiple sclerosis by magnetic resonance imaging , 1994, The Lancet.

[15]  C Becker,et al.  Quantitative assessment of MRI lesion load in multiple sclerosis. A comparison of conventional spin-echo with fast fluid-attenuated inversion recovery. , 1996, Brain : a journal of neurology.

[16]  D. Altman,et al.  Measurement error. , 1996, BMJ.

[17]  S. Goldhaber,et al.  Pulse-spray thrombolysis: the "careful analysis". , 1994, Radiology.

[18]  J. Kurtzke Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[19]  A J Thompson,et al.  Multiple sclerosis lesion detection in the brain: A comparison of fast fluid-attenuated inversion recovery and conventional T2-weighted dual spin echo , 1997, Neurology.

[20]  Joseph V. Hajnal,et al.  Use of Fluid Attenuated Inversion Recovery (FLAIR) Pulse Sequences in MRI of the Brain , 1992, Journal of computer assisted tomography.

[21]  A comparison of conventional and fast spin-echo sequences for the measurement of lesion load in multiple sclerosis using a semi-automated contour technique , 1997, Neuroradiology.

[22]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[23]  J. Martín,et al.  Patterns of disease activity in multiple sclerosis. , 1990, BMJ.

[24]  A. Thompson,et al.  Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study. , 1990, BMJ.

[25]  G. Barker,et al.  Quantification of MRI lesion load in multiple sclerosis: a comparison of three computer-assisted techniques. , 1996, Magnetic resonance imaging.

[26]  R C Grimm,et al.  Initial clinical experience in MR imaging of the brain with a fast fluid-attenuated inversion-recovery pulse sequence. , 1994, Radiology.

[27]  F. Barkhof,et al.  Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis , 1996, Neurology.

[28]  A J Thompson,et al.  Correlations between changes in disability and T2‐weighted brain MRI activity in multiple sclerosis , 1995, Neurology.

[29]  G. Simpson,et al.  Measures of dispersion and variability. , 1939 .

[30]  D. Paty,et al.  Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis , 1993, Neurology.

[31]  D. Altman,et al.  Statistics notes: Measurement error , 1996 .

[32]  G. Barker,et al.  Correlation of magnetization transfer ration with clinical disability in multiple sclerosis , 1994, Annals of neurology.

[33]  Interferon beta-1b in secondary progressive multiple sclerosis--outline of the clinical trial. , 1995, Multiple sclerosis.

[34]  A comparison between fast and conventional spin-echo in the detection of multiple sclerosis lesions , 1994, Neuroradiology.

[35]  J. Kurtzke,et al.  The Disability Status Scale for multiple sclerosis , 1989, Neurology.